Read-only clinical sources
Clinical records remain under the control of their source systems. Approved write-back is limited to governed findings in the QMS.
Trust and governance
Assurance software should make its own evidence visible.
Xaloreli is designed to preserve source ownership, explain rule outcomes and keep qualified people in control of decisions.
Least-privilege access
Role-based permissions, scoped workspaces and time-limited review access reduce unnecessary exposure.
Traceable rules
Rule identity, version, inputs, outcome and reviewer decision are preserved for later inspection.
Source fingerprints
Snapshot fingerprints support reproducibility by recording what each source stated when a check ran.
Data minimisation
The intended model processes only the fields required for the approved assurance purpose and retention period.
Human confirmation
Potential contradictions do not automatically become nonconformances. Authorised people confirm their meaning.
Responsible product boundaries
- Xaloreli does not interpret, alter or release patient results.
- Xaloreli does not grant or guarantee accreditation.
- Xaloreli does not replace professional laboratory, clinical or quality judgement.
- Xaloreli is not intended to rank individual staff performance.
- Any production deployment would require approved data protection, information governance, security and clinical-safety review appropriate to its scope.
Current stage
The current interactive workspace is a concept demonstration using synthetic data. Production controls, validation evidence and contractual governance would be completed and assessed within a defined implementation and pilot scope.
Discuss security and governance